HPV, HCV Should Guide Cancer Patient Prognosis, Treatment

Human papillomavirus and hepatitis C virus infection should be considered during clinical trials of head and neck squamous cell carcinoma and non-Hodgkin’s B-cell lymphoma, respectively. 

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.